NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

Clinical trial NCT05382377 · UNKNOWN

Trial details

NCT number: NCT05382377
Sponsor: jianming xu
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

CRC Solid Tumor

Start date: 2022-05-17
Primary completion: 2024-05-17
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.